Legend Biotech USA Inc. SOMERSET, N.J., May 19, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a live webcast event ...

Legend Biotech USA Inc. SOMERSET, N.J., April 29, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call ...

STOCKHOLM, May 20, 2025 /PRNewswire/ -- Skanska has signed an additional contract with the University of Virginia for the construction of the Paul and Diane Manning Institute of Biotechnology at ...

The FDA is changing how drugs get approved—and that could unleash a biotech revolution. Dylan Jovine from Behind the Markets shares 4 biotech companies on the verge of explosive breakthroughs, ...

"We believe our achievements from this past quarter, including capacity expansion and additional global approvals, are setting the stage for Legend Biotech to achieve company-wide profitability by ...

In a world shaped by biotechnology, why are so few college students exposed to its possibilities early on in their education?

Please enter your username and password below, if you are not yet a member of BioTechniques remember you can register for ...

STOCKHOLM, May 20, 2025 /PRNewswire/ -- Skanska has signed an additional contract with the University of Virginia for the construction of the Paul and Diane Manning Institute of Biotechnology at ...

TORONTO, May 15, 2025 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research ...

BHUBANESWAR: Chairman of Bharat Biotech Dr Krishna Ella called on Chief Minister Mohan Charan Majhi at Lok Seva Bhavan here on Wednesday. Dr Ella and his team discussed the company’s future ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said ...

(Abstract #2241) IO170, also developed using IO Biotech’s T-win® platform, demonstrated significant tumor growth inhibition in breast and prostate cancer mouse models. The TGF- β-directed ...